Literature DB >> 26101306

Efficacy of a Telehealth Intervention on Colonoscopy Uptake When Cost Is a Barrier: The Family CARE Cluster Randomized Controlled Trial.

Laurie E Steffen1, Kenneth M Boucher2, Barbara H Damron3, Lisa M Pappas4, Scott T Walters5, Kristina G Flores6, Watcharaporn Boonyasiriwat7, Sally W Vernon8, Antoinette M Stroup9, Marc D Schwartz10, Sandra L Edwards11, Wendy K Kohlmann4, Jan T Lowery12, Charles L Wiggins6, Deirdre A Hill6, John C Higginbotham13, Randall Burt4, Rebecca G Simmons4, Anita Y Kinney14.   

Abstract

BACKGROUND: We tested the efficacy of a remote tailored intervention Tele-Cancer Risk Assessment and Evaluation (TeleCARE) compared with a mailed educational brochure for improving colonoscopy uptake among at-risk relatives of colorectal cancer patients and examined subgroup differences based on participant reported cost barriers.
METHODS: Family members of colorectal cancer patients who were not up-to-date with colonoscopy were randomly assigned as family units to TeleCARE (N = 232) or an educational brochure (N = 249). At the 9-month follow-up, a cost resource letter listing resources for free or reduced-cost colonoscopy was mailed to participants who had reported cost barriers and remained nonadherent. Rates of medically verified colonoscopy at the 15-month follow-up were compared on the basis of group assignment and within group stratification by cost barriers.
RESULTS: In intent-to-treat analysis, 42.7% of participants in TeleCARE and 24.1% of participants in the educational brochure group had a medically verified colonoscopy [OR, 2.37; 95% confidence interval (CI) 1.59-3.52]. Cost was identified as a barrier in both groups (TeleCARE = 62.5%; educational brochure = 57.0%). When cost was not a barrier, the TeleCARE group was almost four times as likely as the comparison to have a colonoscopy (OR, 3.66; 95% CI, 1.85-7.24). The intervention was efficacious among those who reported cost barriers; the TeleCARE group was nearly twice as likely to have a colonoscopy (OR, 1.99; 95% CI, 1.12-3.52).
CONCLUSIONS: TeleCARE increased colonoscopy regardless of cost barriers. IMPACT: Remote interventions may bolster screening colonoscopy regardless of cost barriers and be more efficacious when cost barriers are absent. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2015        PMID: 26101306      PMCID: PMC4734378          DOI: 10.1158/1055-9965.EPI-15-0150

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  42 in total

1.  Planning prompts as a means of increasing preventive screening rates.

Authors:  Katherine L Milkman; John Beshears; James J Choi; David Laibson; Brigitte C Madrian
Journal:  Prev Med       Date:  2012-10-31       Impact factor: 4.018

Review 2.  Familial colorectal cancer: a review.

Authors:  Franco Armelao; Giovanni de Pretis
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

3.  Inequalities in premature death from colorectal cancer by state.

Authors:  Ahmedin Jemal; Rebecca L Siegel; Jiemin Ma; Farhad Islami; Carol DeSantis; Ann Goding Sauer; Edgar P Simard; Elizabeth M Ward
Journal:  J Clin Oncol       Date:  2014-11-10       Impact factor: 44.544

Review 4.  Hereditary and common familial colorectal cancer: evidence for colorectal screening.

Authors:  N Jewel Samadder; Kory Jasperson; Randall W Burt
Journal:  Dig Dis Sci       Date:  2014-12-12       Impact factor: 3.199

5.  A prospective study of family history and the risk of colorectal cancer.

Authors:  C S Fuchs; E L Giovannucci; G A Colditz; D J Hunter; F E Speizer; W C Willett
Journal:  N Engl J Med       Date:  1994-12-22       Impact factor: 91.245

6.  Can we achieve an 80% screening rate for colorectal cancer by 2018 in the United States?

Authors:  Electra D Paskett; Fadlo R Khuri
Journal:  Cancer       Date:  2015-03-12       Impact factor: 6.860

Review 7.  Improving colorectal cancer screening in primary care practice: innovative strategies and future directions.

Authors:  Carrie N Klabunde; David Lanier; Erica S Breslau; Jane G Zapka; Robert H Fletcher; David F Ransohoff; Sidney J Winawer
Journal:  J Gen Intern Med       Date:  2007-05-30       Impact factor: 5.128

8.  Effects of colon cancer risk counseling for first-degree relatives.

Authors:  Karen Glanz; Alana D Steffen; Lauren A Taglialatela
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

9.  A randomized trial of two print interventions to increase colon cancer screening among first-degree relatives.

Authors:  Susan M Rawl; Victoria L Champion; Linda L Scott; Honghong Zhou; Patrick Monahan; Yan Ding; Patrick Loehrer; Celette Sugg Skinner
Journal:  Patient Educ Couns       Date:  2008-03-04

10.  Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018.

Authors:  Reinier G S Meester; Chyke A Doubeni; Ann G Zauber; S Luuk Goede; Theodore R Levin; Douglas A Corley; Ahmedin Jemal; Iris Lansdorp-Vogelaar
Journal:  Cancer       Date:  2015-03-12       Impact factor: 6.860

View more
  11 in total

1.  Invitation to Screening Colonoscopy in the Population at Familial Risk for Colorectal Cancer.

Authors:  Alexander Bauer; Jürgen F Riemann; Thomas Seufferlein; Max Reinshagen; Stephan Hollerbach; Ulrike Haug; Susanne Unverzagt; Stephanie Boese; Madeleine Ritter-Herschbach; Patrick Jahn; Thomas Frese; Michael Harris; Margarete Landenberger
Journal:  Dtsch Arztebl Int       Date:  2018-10-26       Impact factor: 5.594

2.  Participatory Research to Advance Colon Cancer Prevention (PROMPT): Study protocol for a pragmatic trial.

Authors:  Jamie H Thompson; Melinda M Davis; Michael C Leo; Jennifer L Schneider; David H Smith; Amanda F Petrik; Melissa Castillo; Brittany Younger; Gloria D Coronado
Journal:  Contemp Clin Trials       Date:  2018-02-09       Impact factor: 2.226

Review 3.  Data-Powered Participatory Decision Making: Leveraging Systems Thinking and Simulation to Guide Selection and Implementation of Evidence-Based Colorectal Cancer Screening Interventions.

Authors:  Stephanie B Wheeler; Jennifer Leeman; Kristen Hassmiller Lich; Florence K L Tangka; Melinda M Davis; Lisa C Richardson
Journal:  Cancer J       Date:  2018 May/Jun       Impact factor: 3.360

4.  Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.

Authors:  Anita Y Kinney; Rachel Howell; Rachel Ruckman; Jean A McDougall; Tawny W Boyce; Belinda Vicuña; Ji-Hyun Lee; Dolores D Guest; Randi Rycroft; Patricia A Valverde; Kristina M Gallegos; Angela Meisner; Charles L Wiggins; Antoinette Stroup; Lisa E Paddock; Scott T Walters
Journal:  Contemp Clin Trials       Date:  2018-09-18       Impact factor: 2.226

5.  Development of FamilyTalk: an Intervention to Support Communication and Educate Families About Colorectal Cancer Risk.

Authors:  Deborah J Bowen; Travis Hyams; Mercy Laurino; Timothy Woolley; Stacey Cohen; Kathleen A Leppig; Gail Jarvik
Journal:  J Cancer Educ       Date:  2020-06       Impact factor: 2.037

Review 6.  Epidemiology and Implementation of Cancer Prevention in Disparate Populations and Settings.

Authors:  Ana Maria Lopez; Lauren Hudson; Nathan L Vanderford; Robin Vanderpool; Jennifer Griggs; Mara Schonberg
Journal:  Am Soc Clin Oncol Educ Book       Date:  2019-05-17

7.  Effectiveness of the extended parallel process model in promoting colorectal cancer screening.

Authors:  Wendy C Birmingham; Man Hung; Watcharaporn Boonyasiriwat; Wendy Kohlmann; Scott T Walters; Randall W Burt; Antoinette M Stroup; Sandie L Edwards; Marc D Schwartz; Jan T Lowery; Deirdre A Hill; Charles L Wiggins; John C Higginbotham; Philip Tang; Shirley D Hon; Jeremy D Franklin; Sally Vernon; Anita Y Kinney
Journal:  Psychooncology       Date:  2015-07-20       Impact factor: 3.894

8.  Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.

Authors:  Belinda Vicuña; Harold D Delaney; Kristina G Flores; Lori Ballinger; Melanie Royce; Zoneddy Dayao; Tuya Pal; Anita Y Kinney
Journal:  J Community Genet       Date:  2017-10-02

9.  Comparative Effectiveness of Two Interventions to Increase Colorectal Cancer Screening for Those at Increased Risk Based on Family History: Results of a Randomized Trial.

Authors:  Electra D Paskett; Brittany M Bernardo; Gregory S Young; Mira L Katz; Paul L Reiter; Cathy M Tatum; Jill M Oliveri; Cecilia R DeGraffinreid; Darrell Mason Gray; Rachel Pearlman; Heather Hampel
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-10-30       Impact factor: 4.254

10.  The 3 Bs of cancer care amid the COVID-19 pandemic crisis: "Be safe, be smart, be kind"-A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer.

Authors:  Jung Julie Kang; Richard J Wong; Eric J Sherman; Alisa Rybkin; Sean M McBride; Nadeem Riaz; C Jillian Tsai; Yao Yu; Linda Chen; Kaveh Zakeri; Daphna Y Gelblum; Erin F Gillespie; Marc A Cohen; Jennifer R Cracchiolo; Ian Ganly; Snehal Patel; Bhuvanesh Singh; Jay O Boyle; Benjamin R Roman; Luc G Morris; Ashok R Shaha; Lara A Dunn; Alan L Ho; James V Fetten; Jatin P Shah; David G Pfister; Nancy Y Lee
Journal:  Cancer       Date:  2020-07-08       Impact factor: 6.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.